Navigation Links
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Date:12/8/2008

y Grade 2 and 3 non-hematologic adverse events decreased considerably between months one to three and months four to six(2).

The second study, conducted by researchers at MD Anderson Cancer Center, is an ongoing Phase II clinical trial investigating the efficacy and safety of Tasigna as initial therapy for patients with CML-CP (chronic phase). The current analysis, which includes data from 48 patients, shows that nearly all evaluable patients (96%) achieved CCyR. By six and 12 months, 45% and 52% of patients achieved MMR, respectively. Adverse reactions were manageable with temporary treatment interruptions or dose reductions(1). Notably, there was no marked incidence of severe fluid retention or effusions, side effects commonly observed with other drugs of this class.

About Tasigna

Tasigna (nilotinib) capsules is indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy that included imatinib. Tasigna has been approved in more than 50 countries. The effectiveness of Tasigna is based on hematologic and cytogenetic response rates. There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. Please see Important Safety Information, including Warning below.

Tasigna important safety information

    WARNING: QT PROLONGATION AND SUDDEN DEATHS

    TASIGNA prolongs the QT interval. Sudden deaths have been reported in
    patients receiving nilotinib. TASIGNA should not be used in patients with
    hypokalemia, hypomagnesemia, or long QT syndrome. Hypokalemia or
    hypomagnesemia must be corrected prior to TASIGNA administration and
    should be periodically monitored. Drugs known to prolong the QT interval
    and strong CYP3
'/>"/>
SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... -- Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company ... B virus (HBV) infection, today announced the presentation of ... candidate, NVR 3-778, at the 2015 annual meeting of ... (EASL) in Vienna, Austria . ... performed in a humanized UPA/SCID mouse model was described ...
(Date:4/27/2015)... BRH Medical, Ltd., today announced ... Notification Application (510k) with the US Food and Drug ... Medical expects feedback from the FDA during the next ... following FDA pre-market clearance. Additional pre-market regulatory filings are ... CEO for BRH Medical, commented, "We are thrilled to ...
(Date:4/27/2015)... 27, 2015 Endo International plc (NASDAQ: ENDP ... results before the open of the U.S. financial markets on ... will host a conference call and webcast at 9:00 a.m. ... access the call is U.S./ Canada (866) ... Please dial in 10 minutes prior to the scheduled start ...
Breaking Medicine Technology:Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it ... , before the U.S. financial markets open. , ... Anadys will hold a conference call and webcast on Thursday, July ... its second quarter 2010 financial results and to provide an update on the ...
... SAN DIEGO , July 22 Neurocrine Biosciences, Inc. (Nasdaq: ... financial results after the Nasdaq market closes on Wednesday, July 28, 2010 ... its financial results and provide a Company update Thursday morning, July 29, ... Time ). , , , ...
Cached Medicine Technology:Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results 2Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results 2
(Date:4/27/2015)... According to a recent report from NIDCR (National ... pain, TMJ disorders are the second most prevalent ... addition, the report revealed that TMJ disorders affect about ... estimated 4 billion dollars annually. , These estimates suggest ... symptoms such as headaches, neck pain, tenderness of the ...
(Date:4/27/2015)... April 27, 2015 Beckman Coulter is ... sequencing to study the evolution of neural circuitry and ... will review the mechanisms by which analogous forms of ... body flexions, evolved independently in certain sea slug clades. ... broadcast live April 30, 2015 at 8:00am PT. , ...
(Date:4/27/2015)... 2015 As ISO 27001 has quickly ... companies of all sizes and in all industries, Pivot ... prepare for ISO 27001 certification. The information security audit ... them for ISO 27001 certification. Pivot Point's commitment to ... the number of Lead Implementers and Auditors the company ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Doctors on ... working on a lien basis for over twenty years. So ... find the best doctor in the Fresno area , ... Dilanchian, DC and his team of medical specialists. With ... a massage therapist, Dilanchian Chiropractic is now helping ...
(Date:4/27/2015)... Guided by the extensive work of its community ... collaboration with organizations around the world to identify proven ... essential actions for organizations committed to patient experience ... systems committed to providing the best in experience will:, ... with committed time and focused intent to shape and ...
Breaking Medicine News(10 mins):Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2
... significant reduction in the teaching hours for medical subjects ... in a pathetic state where medical students are unable ... end up confusing one organ with another. In addition ... considerable reduction in the teaching hours for biochemistry, pathology, ...
... launched the Female Condom (FC) in India. It has partnered ... to market// their female condoms in India under the brand ... research before being able to launch the condom in India. ... first year. A pair of Confidom will cost Rs.250/-., ...
... among the teenagers in the recent years. But a new ... that they ever took such vows. // ,The ... good way of gauging how well they adhere to these ... form of public or written declarations to remain a virgin ...
... Mountain View, Calif.-based company is one of the leading ... Hence Long Island politician sued Google. He said that ... child pornography. Jeffrey Toback, a member of the Nassau ... contains pornography involving minors. In regard to this a ...
... used brain scans to try and study the biology of ... the brain pays to the expected pain // determines and ... suggesting that simple diversions could alleviate the misery. ... a new field called neuroeconomics that uses brain imaging to ...
... study undertaken by Ohio State University that chose to study the ... men have no compunctions opening up to others about their ... of the study Julianne Serovich says, “I was very surprised at ... HIV-positive men who deliberate very carefully on whether or not to ...
Cached Medicine News:Health News:Australian Medical Students Lack Anatomy Knowledge 2Health News:Teenagers Often Deny Taken ‘Virginity Pledges 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: